Woodline Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24M | Buy |
1,498,725
+856
| +0.1% | +$13.7K | 0.13% | 241 |
|
|
2025
Q1 | $25.6M | Buy |
1,497,869
+855,143
| +133% | +$14.6M | 0.17% | 179 |
|
|
2024
Q4 | $15.9M | Sell |
642,726
-772,251
| -55% | -$19.1M | 0.11% | 249 |
|
|
2024
Q3 | $40.3M | Sell |
1,414,977
-408,438
| -22% | -$11.6M | 0.34% | 90 |
|
|
2024
Q2 | $48.1M | Buy |
1,823,415
+533,911
| +41% | +$14.1M | 0.46% | 56 |
|
|
2024
Q1 | $41.7M | Buy |
1,289,504
+539,238
| +72% | +$17.4M | 0.38% | 73 |
|
|
2023
Q4 | $31.6M | Sell |
750,266
-213,817
| -22% | -$9.01M | 0.34% | 87 |
|
|
2023
Q3 | $37M | Buy |
964,083
+328,992
| +52% | +$12.6M | 0.43% | 54 |
|
|
2023
Q2 | $12M | Buy |
635,091
+497,499
| +362% | +$9.44M | 0.14% | 183 |
|
|
2023
Q1 | $2.13M | Sell |
137,592
-679,367
| -83% | -$10.5M | 0.03% | 407 |
|
|
2022
Q4 | $14.5M | Sell |
816,959
-947,331
| -54% | -$16.8M | 0.19% | 153 |
|
|
2022
Q3 | $9.85M | Buy |
1,764,290
+1,672,190
| +1,816% | +$9.33M | 0.14% | 198 |
|
|
2022
Q2 | $359K | Buy |
+92,100
| New | +$359K | 0.01% | 588 |
|
|
2021
Q4 | – | Sell |
-241,599
| Closed | -$2.1M | – | 742 |
|
|
2021
Q3 | $2.1M | Sell |
241,599
-3,508,976
| -94% | -$30.5M | 0.03% | 407 |
|
|
2021
Q2 | $39.6M | Buy |
3,750,575
+2,853,958
| +318% | +$30.2M | 0.74% | 30 |
|
|
2021
Q1 | $14.4M | Buy |
896,617
+594,714
| +197% | +$9.54M | 0.32% | 86 |
|
|
2020
Q4 | $13.9M | Buy |
301,903
+160,733
| +114% | +$7.42M | 0.37% | 84 |
|
|
2020
Q3 | $4.97M | Sell |
141,170
-89,738
| -39% | -$3.16M | 0.16% | 129 |
|
|
2020
Q2 | $5.62M | Sell |
230,908
-94,275
| -29% | -$2.3M | 0.22% | 104 |
|
|
2020
Q1 | $5.06M | Buy |
325,183
+52,644
| +19% | +$819K | 0.36% | 84 |
|
|
2019
Q4 | $4.32M | Buy |
+272,539
| New | +$4.32M | 0.18% | 93 |
|